abstract |
The present invention relates to a compound of formula I: [Chemical 1] Or a pharmaceutically acceptable salt or stereoisomer thereof. The compounds of the present invention are inhibitors of histone deacetylase (HDAC) and are useful in the treatment of cell proliferative diseases including cancer. Furthermore, the compounds of the present invention are useful for the treatment of neurodegenerative diseases, schizophrenia, and stroke, among other diseases. |